Is Guerbet SA halal to invest in?

According to Musaffa's Shariah screening methodology, Guerbet SA (GBT.PA) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Guerbet SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Guerbet SA using these criteria to determine its compliance status.

Can Muslims buy shares of Guerbet SA?

Muslim investors may consider investing in Guerbet SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Guerbet SA classified as NOT HALAL?

Musaffa determines the Shariah status of Guerbet SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Guerbet SA updated?

The Shariah compliance status of Guerbet SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Guerbet SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Guerbet SA?

You can check the latest Shariah compliance status of Guerbet SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Guerbet SA GBT.PA

€10.00 €0.03 (0.25%) 1D

Last Updated: May 15, 12:00 AM·XPAR

GBT.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: February 05, 2026

Report Source: 2025 2nd Quarter Report

Guerbet SA. Stock Analysis GBT.PA

France Health Care Micro Cap Report: Q2, 2025

Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company employs 2,746 full-time employees The company produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such as Xenetix, Hexabrix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol, among others. Guerbet SA is also active in the fine chemicals industry through its Simafex subsidiary. The firm operates through its subsidiaries, including Simafex, Medex, SCI KALB, Guerbet LLC, Guerbet Asie Pacifique and Guerbet GmbH, among others.

Key Statistics of Guerbet SA (GBT.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€9.95€10.00

Today's Open

€9.97

Volume

2625.00

P/E Ratio (TTM)

52 Week Range

€8.01€23.70

Market Cap

140.15M

Avg. Volume

3264.68

Dividend Yield

Financial Metrics & Statements of Guerbet SA (GBT.PA)

FAQ's for Guerbet SA (GBT.PA)

According to Musaffa’s Shariah screening methodology, Guerbet SA (GBT.PA) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.